openPR Logo
Press release

Investigation announced for Investors who lost money with Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares

03-07-2023 12:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares over potential securities laws violations.

An investigation for investors in Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares over potential securities laws violations.

An investigation was announced for investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares over potential securities laws violations by Fulcrum Therapeutics, Inc.

Investors who purchased shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) concerning whether a series of statements by Fulcrum Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Cambridge, MA based Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. On July 17, 2019, Fulcrum Therapeutics, Inc announced the pricing of its initial public offering ("IPO") of 4.5 million shares at $16.00 per share, for gross proceeds of $72.0 million.

On February 24, 2023, Fulcrum Therapeutics, Inc announced that the U.S. Food and Drug Administration (FDA) verbally informed the company that it has issued a full clinical hold regarding the Investigational New Drug application for its sickle-cell disease treatment, FTX-6058, due to previously reported preclinical data.

Shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) declined to as low as $5.17 per share on February 27, 2023.

Those who purchased shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares here

News-ID: 2963432 • Views:

More Releases from Shareholders Foundation

Lawsuit filed for Investors in Charge Enterprises, Inc. (formerly NASDAQ: CRGE) in effort to recover losses
Lawsuit filed for Investors in Charge Enterprises, Inc. (formerly NASDAQ: CRGE) …
An investor, who purchased shares of Charge Enterprises, Inc. (formerly NASDAQ: CRGE), filed a lawsuit over alleged violations of Federal Securities Laws by the former CEO and CFO of Charge Enterprises, Inc in connection with certain allegedly false and misleading statements made between December 15, 2021 and February 28, 2024. Investors who purchased shares of Charge Enterprises, Inc. (formerly NASDAQ: CRGE) between December 15, 2021 and February 28, 2024, and continue
Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, Inc. (NASDAQ: OCGN)
Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, In …
A deadline is coming up on June 10, 2024 in the lawsuit filed for certain investors of Ocugen, Inc. (NASDAQ: OCGN) over alleged securities laws violations by Ocugen, Inc. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN ) have certain options and there are strict and short deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potential Wrongdoing
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potent …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation. Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: FMC stocks follows a lawsuit filed against FMC Corporation over
Investigation announced for Long-Term Investors who lost money with Advance Auto Parts, Inc. (NYSE: AAP)
Investigation announced for Long-Term Investors who lost money with Advance Auto …
An investigation was announced for long-term investors in shares of Advance Auto Parts, Inc. (NYSE: AAP) concerning potential breaches of fiduciary duties by certain directors of Advance Auto Parts, Inc. Investors who are current long term investors in Advance Auto Parts, Inc. (NYSE: AAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long

All 5 Releases


More Releases for Fulcrum

Biometrics Market May See a Big Move | Major Giants M2SYS, Aware, Fulcrum Biomet …
The Latest Released Biometrics Market - Outlook and Forecast market study has evaluated the future growth potential of Biometrics Market - Global Outlook and Forecast market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses
Forensic Accounting Market Next Big Thing | Major Giants AccessData, OpenText, F …
Latest published market study on Global Forensic Accounting Market provides an overview of the current market dynamics in the Forensic Accounting space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2027. The study breaks market by revenue and volume (wherever applicable) and price history to estimates size and trend analysis and identifying gaps and opportunities. Some of the players that are in coverage
Investigation announced for Investors in shares of Fulcrum Therapeutics, Inc. (N …
Fulcrum Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Fulcrum Therapeutics, Inc. regarding its business, its prospects and its operations were materially false
Bio-alcohol Market Is Booming Worldwide | BioAmber, Cargill, Fulcrum BioEnergy, …
Global Bio-alcohol Market Market research report 2018 and forecast to 2025 providing a complete analysis of the market size, share, growth, trend, demand, outlook, classification revenue details, competitive scenario, industry Analysis, markets forecast, manufacturers, type, application and Global Bio-alcohol industry overview. It also includes the study of statistical analysis, development trend, end-user analysis, historical data and expert’s opinions. This report focuses on the top manufacturers' Bio-alcohol capacity, production, value, price and
Global Biometric Market Key Players are Fulcrum Biometrics, Daon and Cognitec Sy …
Global Biometric Market Overview: A technological system which utilizes information about an individual to specifically identify that person is called biometric systems. Biometric systems depend on specific data about unique biological traits in order to work effectively. These devices include fingerprint scanners, facial recognition, hand/palm recognition, iris scanner, voice recognizer, vein scanner and others. These biometric devices are very useful where higher level of security is needed such as banks, law
Pharmacy Automation Device Market: AmerisourceBergen Corporation, ForHealth Tech …
MarketResearchReports.Biz adds “Global Pharmacy Automation Device Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Pharmacy Automation Device market and the growth estimates for the forecasted period. This report studies the global Pharmacy Automation Device market status and forecast, categorizes the global Pharmacy Automation Device market size (value & volume) by key players, type, application, and region. This report